With investment into the Treg field at an all time high, excitement is overflowing at the prospect of these remarkable cells being game-changers in the long-term treatment of...

Global pharmaceutical R and D spend is increasing rapidly, now topping a staggering $238bn globally. Increased spend, coupled with unpredictable inflation-related price...

Our mission is to showcase the most exciting investment opportunities in the sector and connect those businesses with financial investors and strategic corporate partners....

The ISAKOS Congress is the signature event of ISAKOS, joining together world leaders in the specialties of arthroscopy, knee surgery, and orthopaedic sports medicine. The...

Insurance is at a critical inflection point. Economic upheaval from rising inflation is amplifying the increase in severity and frequency of catastrophe losses, the current...

As the biggest industry-led meeting on novel vector development, the 3rd Annual Next Generation Gene Therapy Vectors Summit (https://ter.li/bv6v3u) (June 27-29, 2023 | Boston,...

New doors open for Cytokine drug developers to treat diseases both in and beyond oncology with novel masking and tissue targeting mechanisms and the abundance of preclinical...

Over the last 12 months, we have seen many combination therapies enter Phase I and II trials with both successes and challenges, particularly in solid tumors. The FDA...

It's a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R and D and commercial...

The Fusion Protein Engineering and Developability Summit is the definitive event catering to drug developers with novel fusion protein pipelines - it is a conference not to be...

The most anticipated event of the mRNA calendar year is back with a bang! The mRNA-Based Therapeutics Summit is returning for its 3rd year this July as the one-stop-shop for...

The inaugural RNA Assay Development and Screening Summit is the only industry-focused RNA assay discovery networking and discussion forum, dedicated to addressing and...

The Inaugural Gene Therapy Potency Summit (August 29-31) is dedicated to providing you with tools to identify, characterize and measure potency, enabling you to take tactical...

2023 is set to be a landmark year for lipid-based delivery technology development and the 2nd Next-Generation Lipid-Based Nanoparticle Delivery Summit returns to unite 140+...

Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE. This decade of success has resulted in explosive investment into the...

LSX are known for bringing life science investors together to assess and meet with the most promising up-and-coming biotech companies. When the first mRNA vaccines hit the...

The 3rd Annual Mitochondria-Related Drug Development Summit returns for the first in-person meeting of 80+ industry experts to explore the unique opportunities of targeting...

For payers, this is the first and only congress dedicated to needs of PI teams, covering pressing issues such as: - Structuring of PI departments - Prioritizing pre-payment...

For nearly a decade, the LSX World Congress has been bringing together the executives that matter to the future of healthcare and life science strategy, investment, partnering...

Now entering its fifth year, the Women's Health Innovation Summit USA has evolved significantly since the first convening. Having grown from 99 attendees in 2019 to just over...

Keeping pace with the rapid changes in evidence-based critical care medicine is difficult for specialty-trained intensivists; for non-intensivists, the challenge of staying up...

With the approval of the second-ever KRAS G12C inhibitor, the field can once again celebrate irrevocable proof that RAS is druggable! However, with so many KRAS G12C drugs in...